> top > docs > PMC:1472690 > spans > 4013-4225 > annotations

PMC:1472690 / 4013-4225 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T1582 0-1 -LRB- denotes [
T1583 1-3 CD denotes 20
T1584 3-4 -RRB- denotes ]
T1585 5-14 NN denotes treatment
T1586 15-23 VB denotes resulted
T1587 24-26 IN denotes in
T1588 27-36 VB denotes decreased
T1589 37-43 JJ denotes septic
T1590 44-53 NN denotes morbidity
T1591 54-57 CC denotes and
T1592 58-67 NN denotes mortality
T1593 68-76 VB denotes mediated
T1594 77-80 IN denotes via
T1595 81-91 NN denotes inhibition
T1596 92-94 IN denotes of
T1597 95-99 NN denotes NFκB
T1598 100-103 CC denotes and
T1599 104-115 NN denotes stimulation
T1600 116-118 IN denotes of
T1601 119-122 DT denotes the
T1602 123-148 NN denotes phosphoinositide-3-kinase
T1603 149-150 -LRB- denotes (
T1604 150-154 NN denotes PI3K
T1605 154-155 -RRB- denotes )
T1606 156-163 NN denotes pathway
T1607 164-165 -LRB- denotes [
T1608 165-170 CD denotes 21,22
T1609 170-171 -RRB- denotes ]
T1610 173-178 DT denotes These
T1611 179-182 CC denotes and
T1612 183-188 JJ denotes other
T1613 189-195 NN denotes animal
T1614 196-203 NN denotes studies
T1615 204-205 -LRB- denotes [
T1616 205-210 CD denotes 23,24
T1617 210-211 -RRB- denotes ]
R721 T1583 T1582 arg2Of 20,[
R722 T1584 T1582 arg3Of ],[
R724 T1585 T1582 arg1Of treatment,[
R725 T1585 T1586 arg1Of treatment,resulted
R728 T1586 T1587 arg1Of resulted,in
R729 T1590 T1588 arg2Of morbidity,decreased
R730 T1590 T1589 arg1Of morbidity,septic
R731 T1590 T1591 arg1Of morbidity,and
R732 T1591 T1587 arg2Of and,in
R733 T1591 T1593 arg2Of and,mediated
R734 T1592 T1591 arg2Of mortality,and
R735 T1593 T1594 arg1Of mediated,via
R736 T1595 T1594 arg2Of inhibition,via
R737 T1595 T1596 arg1Of inhibition,of
R738 T1597 T1598 arg1Of NFκB,and
R739 T1598 T1596 arg2Of and,of
R740 T1598 T1600 arg1Of and,of
R741 T1599 T1598 arg2Of stimulation,and
R742 T1604 T1603 arg2Of PI3K,(
R743 T1605 T1603 arg3Of ),(
R744 T1606 T1600 arg2Of pathway,of
R745 T1606 T1601 arg1Of pathway,the
R746 T1606 T1602 arg1Of pathway,phosphoinositide-3-kinase
R747 T1606 T1603 arg1Of pathway,(
R748 T1606 T1607 arg1Of pathway,[
R749 T1608 T1607 arg2Of "21,22",[
R750 T1609 T1607 arg3Of ],[
R751 T1614 T1610 arg1Of studies,These
R752 T1614 T1611 arg1Of studies,and
R753 T1614 T1612 arg1Of studies,other
R754 T1614 T1613 arg1Of studies,animal
R755 T1614 T1615 arg1Of studies,[
R757 T1616 T1615 arg2Of "23,24",[
R758 T1617 T1615 arg3Of ],[

GO-BP

Id Subject Object Predicate Lexical cue
T1098 150-154 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K

GO-MF

Id Subject Object Predicate Lexical cue
T1209 150-154 http://purl.obolibrary.org/obo/GO_0016303 denotes PI3K

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T2879 123-139 Entity denotes phosphoinositide
T2895 150-154 Protein denotes PI3K
T2869 142-148 Protein denotes kinase
T2872 95-99 Protein denotes NFκB

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T2434 0-1 NNP denotes [
T2435 1-3 CD denotes 20
T2436 3-4 NNP denotes ]
T2437 5-14 NN denotes treatment
T2438 15-23 VBD denotes resulted
T2439 24-26 IN denotes in
T2440 27-36 VBN denotes decreased
T2441 37-43 JJ denotes septic
T2442 44-53 NN denotes morbidity
T2443 54-57 CC denotes and
T2444 58-67 NN denotes mortality
T2445 68-76 VBD denotes mediated
T2446 77-80 IN denotes via
T2447 81-91 NN denotes inhibition
T2448 92-94 IN denotes of
T2449 95-99 NNP denotes NFκB
T2450 100-103 CC denotes and
T2451 104-115 NN denotes stimulation
T2452 116-118 IN denotes of
T2453 119-122 DT denotes the
T2454 123-148 JJ denotes phosphoinositide-3-kinase
T2455 149-150 -LRB- denotes (
T2456 150-154 NNP denotes PI3K
T2457 154-155 -RRB- denotes )
T2458 156-163 NN denotes pathway
T2459 164-165 NNP denotes [
T2460 165-170 CD denotes 21,22
T2461 170-171 NNP denotes ]
T2462 171-172 . denotes .
T2463 173-178 DT denotes These
T2464 179-182 CC denotes and
T2465 183-188 JJ denotes other
T2466 189-195 NN denotes animal
T2467 196-203 NNS denotes studies
T2468 204-205 NNP denotes [
T2469 205-210 CD denotes 23,24
T2470 210-211 NNP denotes ]
R1441 T2434 T2438 nsubj [,resulted
R1442 T2435 T2437 nummod 20,treatment
R1444 T2436 T2437 compound ],treatment
R1445 T2437 T2438 nsubj treatment,resulted
R1446 T2438 T2438 ROOT resulted,resulted
R1448 T2439 T2438 prep in,resulted
R1449 T2440 T2442 amod decreased,morbidity
R1450 T2441 T2442 amod septic,morbidity
R1452 T2442 T2439 pobj morbidity,in
R1453 T2443 T2442 cc and,morbidity
R1454 T2444 T2442 conj mortality,morbidity
R1456 T2445 T2438 conj mediated,resulted
R1457 T2446 T2445 prep via,mediated
R1458 T2447 T2446 pobj inhibition,via
R1460 T2448 T2447 prep of,inhibition
R1461 T2449 T2448 pobj NFκB,of
R1462 T2450 T2447 cc and,inhibition
R1463 T2451 T2447 conj stimulation,inhibition
R1465 T2452 T2447 prep of,inhibition
R1466 T2453 T2454 det the,phosphoinositide-3-kinase
R1467 T2454 T2452 pobj phosphoinositide-3-kinase,of
R1468 T2455 T2458 punct (,pathway
R1469 T2456 T2458 nmod PI3K,pathway
R1471 T2457 T2458 punct ),pathway
R1472 T2458 T2454 appos pathway,phosphoinositide-3-kinase
R1473 T2459 T2461 compound [,]
R1475 T2460 T2461 compound "21,22",]
R1476 T2461 T2458 appos ],pathway
R1477 T2462 T2438 punct .,resulted
R1480 T2464 T2463 cc and,These
R1481 T2465 T2467 amod other,studies
R1482 T2466 T2467 compound animal,studies
R1484 T2467 T2463 conj studies,These
R1485 T2468 T2470 compound [,]
R1486 T2469 T2470 compound "23,24",]
R1488 T2470 T2467 appos ],studies

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T1999 95-99 Protein denotes NFκB
T2000 123-148 Protein denotes phosphoinositide-3-kinase
T2001 150-154 Protein denotes PI3K
T2002 81-91 Negative_regulation denotes inhibition
R1069 T1999 T2002 themeOf NFκB,inhibition